Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.  

Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.

Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the consultation.

Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.

Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.

7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate

EC / List no: 219-207-4 CAS no: 2386-87-0
CLP Annex VI Index number
Further substance information
Status
Opinion Adopted
Date of intention
19-ago-2020
Expected date of submission
31-mar-2021
Submitted for accordance check
16-mar-2021
Final submission date
15-lug-2021
Withdrawal date
Legal deadline for opinion adoption
14-gen-2023
Submitter
Ireland
Submitter's email
Harmonised classification at the time of the proposal
Specific concentration limits at the time of the proposal
Proposed harmonised classification by the dossier submitter
Skin Sens. 1, H317
Muta. 2, H341
STOT RE 2, H373
Proposed specific concentration limits by the dossier submitter
H373 (nasal cavity)
Regulatory programme
Chemical registered under REACH
Remarks
The substance was evaluated by Ireland in 2013 and the outcome of the substance evaluation process (2018) was a recommendation for harmonised classification for skin sens 1, STOT RE 2 and Muta 2.
Start of consultation
23-ago-2021
Deadline for commenting
22-ott-2021
Hazard classes open for commenting
Skin sensitisation
Germ cell mutagenicity
Specific target organ toxicity — repeated exposure
CLH report
Annexes to the CLH report
Date of opinion
02-giu-2022
RAC Opinion
Background document
RCOM (Comments received)
Attachments received during consultation (excluding journal articles)
Minority opinion(s)
Other annexes
ATP number and date
Link to ATP
Latest update
30-ago-2022
First published
12-ott-2020